Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2016

Jun 2, 2016

30016_dirs_2016-06-02_c99b55f7-a8d9-48a8-8c60-bbce0b96566b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-06-01

Reporting Person: Williams Michael J PhD (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-01 Common Stock M 2598 Acquired 42696 Direct
2016-06-01 Common Stock F 805 $88.18 Disposed 41891 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-01 Restricted Stock Unit $ M 2598 Disposed Common Stock (2598) Direct

Footnotes

F1: Includes 87 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2016.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning June 1, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.

F3: Not applicable.